Effect of drug class on association of beta-blocker with ovarian cancer survival [1]

Cancer-related productivity losses in emerging economies [2]

Health-related quality of life in women after colposcopy: Results from a patient survey [3]

Comparing the costs of three prostate cancer follow-up strategies: A cost-minimisation analysis (iHEA) [4]

Comparing the costs of three prostate cancer follow-up strategies: A cost-minimisation analysis (MASCC) [5]

Associations between pre- and post-diagnostic use of beta-blockers and ovarian cancer survival [6]

A meta-analytic approach to large scale competing risks regression [7]

Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12 month longitudinal study [8]

"HPV is the nicer name for genital warts": beliefs, misconceptions, unanswered questions and factors influencing information needs among women who have a HPV test within routine follow-up [9]

Men's experience of prostate biopsy in Ireland: Results from the all-Ireland PiCTure study [10]